Dongwha Pharm Acquires 19.6 Billion KRW Worth of Medisay Shares... Stake Reaches 52.9%
[Asia Economy Reporter Yoo Byung-don] Dongwha Pharm announced on the 24th that it will acquire 2,018,198 shares of medical device company Medissei for approximately 19.6 billion KRW.
After acquiring the shares, Dongwha Pharm's stake in Medissei will be 52.9%. The scheduled date for the share acquisition is September 24 of this year.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- Court Partially Grants Samsung Electronics' Injunction to Prohibit Industrial Action... 100 Million Won Penalty Per Day for Violations
- President Lee Attends Gwangju May 18 Ceremony... Declares 'A Nation Where the People Are the True Owners' at Democratic Cemetery
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
Dongwha Pharm stated that the purpose of this share acquisition is "business diversification through investment after acquisition."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
